A modified surgical approach for treating lower eyelid inversion (entropion) in Asian patients

ISRCTN ISRCTN39804797
DOI https://doi.org/10.1186/ISRCTN39804797
ClinicalTrials.gov (NCT) Nil known
Clinical Trials Information System (CTIS) Nil known
Protocol serial number 201801039B0D001
Sponsor Chiayi Chang Gung Memorial Hospital
Funder Chiayi Chang Gung Memorial Hospital
Submission date
18/03/2020
Registration date
10/05/2020
Last edited
18/05/2020
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Eye Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
Lower eyelid involutional entropion causes the eyelid margin and eyelashes to rotate inward and irritate the eye. It usually occurs in individuals above 50 years of age. Many surgical methods have been designed to correct the contributing factors, but even so, recurrence is still a troublesome complication. To reduce the risk for recurrence, surgeons have modified the procedures according to the patients. The type of surgical procedure to be adopted should also be determined according to racial anatomical differences. Therefore, researchers have proposed a new surgical method modified from the Quickert procedure. This surgical design can cover most of the triggering causes in Asians. The aim of this study is to review the outcomes of patients who have undergone this surgery during the past five years (from January 2012 to October 2017).

Who can participate?
Patients aged over 55 years who had been diagnosed with involutional entropion and underwent the new surgical technique for repair

What does the study involve?
Information is collected from each patient’s medical record including surgical success, complications and recurrence. All surgical procedures and examinations are performed by a single oculoplastic surgeon (CY Chen) using consistent techniques.

What are the possible benefits and risks of participating?
The surgical procedure was modified from the Quickert procedure in some steps, and the Quickert procedure has been well confirmed in the correction of lower lid entropion. The modified surgical procedure is thought to be safe and effective, and result in less recurrence, overcorrection and complication.

Where is the study run from?
Chang Gung Memorial Hospital (Taiwan)

When is the study starting and how long is it expected to run for?
July 2018 to January 2019

Who is funding the study?
Chang Gung Memorial Hospital (Taiwan)

Who is the main contact?
Chauyin Chen
m7043@cgmh.org.tw
ccy423@gmail.com

Contact information

Mr Chauyin Chen
Scientific

6 , Sec, West, Chia Pu Road, Pu Zih City
Chiayi
61363
Taiwan

Phone +886 (0)975353261
Email m7043@cgmh.org.tw

Study information

Primary study designObservational
Study designRetrospective observational cross-sectional cohort study
Secondary study designCross sectional study
Study type Participant information sheet
Scientific titleUsing a modified Quickert procedure combined with prolapsed fat removal to correct involutional lower eyelid entropion in Asians
Study objectivesThe researchers propose a new surgical method modified from Quickert procedure. This surgical design can cover most of the triggering causes in Asians.
Ethics approval(s)Approved 04/07/2018, Chang Gung Medical Foundation Institutional Review Board (199, Tung Hwa North Road, Taipei, Taiwan, 10507, Republic Of China; +886 (0)3 3196200; ccyi@cgmh.org.tw), IRB No.: 201801039B0
Health condition(s) or problem(s) studiedInvolutional lower eyelid entropion
InterventionEvery outpatient receiving the modified Quickert procedure is arranged regular follow-ups at the outpatient clinic at the time of pre-op, 1 week and 2 months after surgery, and then when needed according to the patient's other chronic eye diseases.
Intervention typeProcedure/Surgery
Primary outcome measure(s)

Success rate: successful surgery was defined as a normal eyelid position at rest, and inability to induce entropion by provocative test. Success rate was measured using external eye photography and provocative test performed in clinic, measured at follow-up after 2 months, and also after 12 months for patients when needed due to their other ocular diseases

Key secondary outcome measure(s)

Measured at follow-up after 2 months, and also after 12 months for patients when needed due to their other ocular diseases:
1. Recurrence rate: recurrence defined as either the majority of eyelashes remained in contact with the globe or persistent irritation/keratitis in the presence of residual in-turned eyelashes
2. Overcorrection rate: overcorrection defined as ectropion and conjunctiva inside out
3. Complication rate: complication defined as formation of symblepharon, wound infection or wound dehiscence during the follow-up period

Completion date03/01/2019

Eligibility

Participant type(s)Patient
Age groupAdult
SexAll
Target sample size at registration150
Total final enrolment97
Key inclusion criteria1. Patients aged > 55 years
2. Involutional lower eyelid entropion confirmed by the presenting of trichiasis, eyelid laxity, vertical laxity, and abundant of orbicularis
Key exclusion criteria1. Patients with concurrent eyelid pathologies such as malignant tumor, cicatricial entropion caused by trauma, infection or inflammatory, spastic entropion caused by essential blepharospasm, hemifacial spasm-involutional entropion
2. Post-operative follow-up period of < 2 months
3. Aged < 55 years at the time of surgery
4. Patients with any history of previous surgery for involutional entropion
Date of first enrolment01/01/2012
Date of final enrolment31/10/2017

Locations

Countries of recruitment

  • Taiwan

Study participating centre

Chang Gung Memorial Hospital
Department of Ophthalmology
6, Sec, West, Chia Pu Road, Pu Zih City
Chiayi
61363
Taiwan

Results and Publications

Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryOther
IPD sharing planThe datasets generated and/or analyzed during the current study during this study will be included in the subsequent results publication.

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Basic results 29/04/2020 18/05/2020 No No
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes

Additional files

ISRCTN39804797_BasicResults_29Apr20.pdf
uploaded 18/05/2020

Editorial Notes

18/05/2020: The basic results of this trial have been uploaded as an additional file.
14/04/2020: Trial's existence confirmed by the Chang Gung Medical Foundation Institutional Review Board.